Lin Yan

Lin received an MD from Beijing Medical University, a Masters of Science in statistics and a PhD in cardiovascular physiology from Rutgers University, and an MBA in Healthcare Management from the Wharton School at the University of Pennsylvania.

Lin recently joined Morgan Stanley in New York City, in the firm's investment banking division. 

​

Previously, Lin was an associate at L Capital Partners. At L Capital, Lin was responsible for identifying investment opportunities in the healthcare sector. She evaluated new drugs and healthcare technologies from the medical perspective and made investment recommendations based on her due diligence and financial analyses. 

​

Immediately prior to joining L Capital Partners, Lin was with Goldman, Sachs & Co. as an investment banking associate in the Healthcare Group and biotechnology sector. She served as financial advisor on numerous transactions, including mergers & acquisitions, debt/equity financing, buy-side and sell-side advisories, initial and follow-on public offerings, and evaluation of investment opportunities. Prior to that, Lin served as Director of Medical Research at Health Network America/ Triveris, where she developed models to forecast the prevalence of various medical conditions in specific populations. 

​

As a member of the faculty at Xinjiang University, China, Lin taught physiology to medical students.

Lin Yan is member of Kauffman Fellows Class 13. She performed her fellowship at L Capital Partners with mentor Ting Pau Oei.